Medallion Acquires Andros to Unify One Million Providers onto an AI‑Native Credentialing Platform
MedallionAcquirer
Medallion announced on September 15, 2026 that it has acquired Andros, an NCQA‑certified credential verification organization, to unify more than one million healthcare providers across nearly 400 health plans on a single AI‑native credentialing platform. Financial terms were not disclosed.
Medallion has acquired Andros, merging the two firms to create the United States’ largest AI‑native credentialing platform. The transaction, announced on September 15, 2026, brings together Medallion’s payer‑enrollment and AI‑driven verification tools with Andros’s long‑standing CVO relationships, covering over one million providers in roughly 400 health‑plan networks. Financial details of the deal were not disclosed, and Bailey & Company acted as exclusive financial advisor to Andros.
Deal Terms
The acquisition combines Medallion’s automated primary‑source data extraction, OCR‑based license verification, and AI‑agent outreach with Andros’s accredited credential verification services. Andros, founded in 2013, processes about 300,000 credentialing files annually and holds 11‑out‑of‑11 NCQA accreditation standards. Post‑close, Andros’s enterprise customers will transition onto Medallion’s platform, gaining access to real‑time application tracking, continuous monitoring, and delegated credentialing capabilities.
Strategic Rationale
Historically, the credentialing market has been split between labor‑intensive BPO verification services and point‑solution SaaS tools that rarely interact with payer‑side directory management. By unifying provider‑onboarding with payer enrollment, Medallion aims to eliminate that fragmentation, offering a single system of record for the entire provider lifecycle. The combined platform reduces verification cycles from weeks to days, automates multi‑state license checks, and embeds human‑in‑the‑loop specialists only for exception handling. The move positions Medallion to challenge legacy verification providers and data aggregators that have dominated the space.
The integration also expands Medallion’s addressable market. With more than one million clinicians now on its platform, the company can pursue deeper cross‑sell opportunities, such as continuous monitoring services and analytics for health‑plan compliance. For Andros, the partnership provides a technology runway to scale its CVO services beyond the current 200‑plus provider networks it supports across all 50 states.
The deal underscores a broader trend of consolidation in health‑tech SaaS, where AI‑driven solutions are being paired with established compliance and verification providers to create end‑to‑end platforms. As payer networks increasingly demand faster, more accurate credentialing to meet regulatory and cost‑containment pressures, the combined entity is well‑positioned to capture a larger share of the $5‑6 billion credentialing market.
Why It Matters
For Medallion, the acquisition instantly scales its data set and customer base, giving it a defensible moat built on both AI capabilities and deep payer relationships. Competitors that rely solely on SaaS intake forms now face a platform that can handle the full credentialing lifecycle, from primary source verification to ongoing monitoring, potentially accelerating churn among legacy BPO providers.
Andros gains access to a modern AI stack that can dramatically improve processing speed and reduce manual effort, allowing it to expand its service offering without proportionally increasing headcount. The combined platform also creates a more attractive proposition for health‑plan investors seeking integrated solutions, which could translate into higher net revenue retention and upsell potential across the unified customer base.
Key Points
- Medallion announced the acquisition of Andros on September 15, 2026.
- The deal creates the largest AI‑native credentialing platform in the United States.
- Combined, the platforms manage over one million healthcare providers across nearly 400 organizations.
- Financial terms were not disclosed; Bailey & Company advised Andros.
- Andros brings NCQA‑certified CVO capabilities and processes roughly 300,000 credentialing files annually.
Analysis
The Medallion‑Andros merger signals a pivotal shift toward end‑to‑end, AI‑driven credentialing solutions in health‑tech SaaS. By uniting a robust AI engine with an NCQA‑certified verification organization, the combined entity can command higher ARR multiples, as investors increasingly value platforms that reduce manual overhead and accelerate payer onboarding cycles. The expanded provider base—exceeding one million clinicians—offers a sizable cross‑sell runway for continuous monitoring and compliance analytics, potentially boosting net revenue retention above industry averages.
From a market perspective, the transaction reflects accelerating consolidation in credentialing, a sub‑segment that has lagged behind broader SaaS adoption. As health plans confront tighter regulatory timelines and cost pressures, platforms that can deliver real‑time verification and automated enrollment will attract premium pricing. For operators, the integrated platform reduces the need for multiple vendor contracts, streamlining the provider lifecycle and lowering total cost of ownership. Investors may view the deal as a catalyst for further M&A activity, with valuation multiples likely to compress as AI‑native capabilities become a baseline expectation. Overall, the acquisition positions Medallion to capture a larger share of the $5‑6 billion credentialing market, while offering a template for AI‑centric consolidation across other health‑tech verticals.